English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/165825
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Selective Synthesis of the Human Drug Metabolite 5′-Hydroxypropranolol by an Evolved Self-Sufficient Peroxygenase

AutorGómez de Santos, Patricia ; Canelas, Marina; Tieves, Florian; Younes, Sabry H. H.; Molina-Espeja, Patricia ; Hofrichter, Martin; Hollmann, Frank; Guallar, Victor; Alcalde Galeote, Miguel
Palabras clave5′-hydroxypropranolol
Directed evolution
Human drug metabolites
In situ H2O2 generation system
Peroxidative activity
Peroxygenative activity
Unspecific peroxygenase
Fecha de publicación19-abr-2018
EditorAmerican Chemical Society
CitaciónACS Catalysis 8(6): 4789-4799 (2018)
ResumenPropranolol is a widely used beta-blocker that is metabolized by human liver P450 monooxygenases into equipotent hydroxylated human drug metabolites (HDMs). It is paramount for the pharmaceutical industry to evaluate the toxicity and activity of these metabolites, but unfortunately, their synthesis has hitherto involved the use of severe conditions, with poor reaction yields and unwanted byproducts. Unspecific peroxygenases (UPOs) catalyze the selective oxyfunctionalization of C–H bonds, and they are of particular interest in synthetic organic chemistry. Here, we describe the engineering of UPO from Agrocybe aegerita for the efficient synthesis of 5′-hydroxypropranolol (5′-OHP). We employed a structure-guided evolution approach combined with computational analysis, with the aim of avoiding unwanted phenoxyl radical coupling without having to dope the reaction with radical scavengers. The evolved biocatalyst showed a catalytic efficiency enhanced by 2 orders of magnitude and 99% regioselectivity for the synthesis of 5′-OHP. When the UPO mutant was combined with an H2O2 in situ generation system using methanol as sacrificial electron donor, total turnover numbers of up to 264 000 were achieved, offering a cost-effective and readily scalable method to rapidly prepare 5′-OHP.
Versión del editorhttp://dx.doi.org/10.1021/acscatal.8b01004
URIhttp://hdl.handle.net/10261/165825
DOI10.1021/acscatal.8b01004
E-ISSN2155-5435
Aparece en las colecciones: (ICP) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
human_drug_metabolite_Gomez.pdf4,69 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.